Bipolar Disorder: Microdosing Psilocybin to Lessen Depressive Symptoms

Simple item page
dc.contributor.authorHeath, Ashley N
dc.date.accessioned2021-04-15T16:49:25Z
dc.date.available2021-04-15T16:49:25Z
dc.date.issued2021
dc.description.abstractResearch on microdosing psilocybin as a novel treatment option for bipolar depression is still in its infancy; however, new research studies show significant improvement in major depression and treatment-resistant depression after a one-time large dose of psilocybin. The purpose of this systematic literature review was to evaluate recent studies on psilocybin and the reduction of depressive symptoms in participants with treatment-resistant depression or major depression, as well as the benefits of microdosing psilocybin. A total of seven studies met the criteria for statistical data, population characteristics, and the use of psilocybin for depression. One study examined the benefits versus challenges of microdosing psilocybin recreationally along with depression screening via online self-reporting questionnaires and DAS-A-17 scale. The additional six studies evaluated the effects of psilocybin on depression, anxiety, and mood disturbances. Quantitative results indicate that psilocybin can significantly reduce depressive symptomatology in treatment-resistant depression, along with anxiety, neuroticism, anhedonia, anger and hostility, and impulsiveness. Results also found an increase in joy, awe, the feeling of love, and positive emotions. The researcher discussed the strengths, limitations, and suggestions for future research. Further studies with more rigorous analysis, larger and more inclusive sample sizes, and increased double-blind and controlled designs would be necessary to understand treatment options involving psilocybin for depression.en_US
dc.identifier.urihttp://hdl.handle.net/20.500.12264/340
dc.language.isoen_USen_US
dc.subjectPsilocybinen_US
dc.subjectBipolar II Disorderen_US
dc.subjectDepressionen_US
dc.subjectMicrodosingen_US
dc.subjectSerotonin Agonisten_US
dc.titleBipolar Disorder: Microdosing Psilocybin to Lessen Depressive Symptomsen_US
dc.typeThesisen_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Heath 2021 Bipolor Disorder Microdosing Psilocybin to Lessen Depressive Symptoms.pdf
Size:
338.65 KB
Format:
Adobe Portable Document Format
Description:
Manuscript
Download

Collections

Master of Science in Psychology Student Thesis Collection